ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2023

Jun 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2023-06-22

Reporting Person: BOESS CARSTEN (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-22	Stock Option (Right to Buy)	$21.56	A	25850	Acquired	2033-06-22	Common Stock (25850)	Direct

Footnotes

F1: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.